Ayahuasca: A risk for travellers?

被引：15
作者：
Bauer, Irmgard L. [1 ]
机构：
[1] James Cook Univ, Coll Healthcare Sci, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia
来源：
TRAVEL MEDICINE AND INFECTIOUS DISEASE | 2018年 / 21卷
关键词：
D O I：
10.1016/j.tmaid.2018.01.002
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：74 / 76
页数：3
相关论文
共 5 条
  • [1] International travelers with infectious diseases determined by pathology results, Centers for Disease Control and Prevention - United States, 1995-2015
    Angelo, Kristina M.
    Barbre, Kira
    Shieh, Wun-Ju
    Kozarsky, Phyllis E.
    Blau, Dianna M.
    Sotir, Mark J.
    Zaki, Sherif R.
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2017, 19 : 8 - 15
  • [2] Callaway JC, 1998, J PSYCHOACTIVE DRUGS, V30, P367
  • [3] Dominguez-Clave E., 2016, BRAIN RES B
  • [4] Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
    Gable, Robert S.
    [J]. ADDICTION, 2007, 102 (01) : 24 - 34
  • [5] Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks
    Kavenska, Veronika
    Simonova, Hana
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 2015, 47 (05) : 351 - 359
1